News

Eisai Co., Ltd and MAMORIO, Inc announced that they have entered into an agreement to collaborate on the development of the Me-MAMORIO1 tracking tool to support people with dementia going out. The two companies will conduct a demonstration experiment...

Valeant Pharmaceuticals International, Inc announced that it has entered into a licensing agreement with Norgine B.V. ("Norgine"); under which Valeant has obtained the rights to develop and commercialize NER1006 Powder for Oral Solution in the U.S. and Canada. NER1006...

Optima has expanded its machine range to include new entry-level solutions. These solutions currently include the flexible and completely attuned filling and closing machines OPTIMA FM1 and CM1. These new systems can also be used as stand-alone units. Turnkey...

Aphena Pharma Solutions is pleased to announce the relocation and major expansion of our chocolated pharmaceutical manufacturing operations.   Offerings include brand-equivalent formulations of senna OTC laxatives (compare to Ex-Lax ®) marketed as private-label products. All production has been...

Kyowa Hakko Kirin Co Ltd has completed the construction of the HB6 Plant in the Takasaki Plant (Takasaki city, Gunma, Plant Manager: Hitoshi Arai) in August 2016.  The new HB6 facility is equipped with one of the largest bioreactors...

Mylan N.V. announced the U.S. launch of Dextroamphetamine Sulfate Extended-release Capsules, 5 mg, 10 mg, and 15 mg, a generic version of Amedra Pharmaceuticals LLC's Dexedrine®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for...

Servier announces the launch of a bioproduction programme at its site in Gidy. First research batches in 2019 and first clinical batches in 2020.   Today, approximately 50% of the new anticancer treatments originate from biotechnologies, and the partnerships...